Latest Continuous Disclosure News

IRIS Metals has completed acquisition of 87 federal mining claims in South Dakota but will not proceed with the private land component of the Ingersoll Project due to unforeseen issues. The company is reassessing options while maintaining its broader critical minerals strategy.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

Babylon Pump & Power’s shares remain suspended from ASX trading as the company delays disclosure of a material transaction and capital raising, prolonging market uncertainty beyond the initial deadline.

Key Petroleum’s shares more than doubled in April with no new material information to explain the jump, as the company awaits delayed government approval for a key project.

Papyrus Australia (ASX: PPY) has secured $175,000 through a share placement alongside convertible note conversions and related party loans, aiming to fund commercialisation and fulfil a key contract for biodegradable Collar Keeper® products.

Xstate Resources has issued a cleansing prospectus to remove trading restrictions on recently placed shares and associated options, following a $1.69 million capital raise priced at 3.3 cents per share. The offer includes free attaching options to placement participants, brokers, and consultants, subject to shareholder approval.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Tusker Minerals Ltd has seen its TSKO securities suspended from ASX quotation immediately due to non-compliance with listing rules. The suspension applies solely to this security class while the company works to meet regulatory requirements.

Monash IVF has turned down a revised $0.90 per share acquisition proposal from a consortium led by Genesis Capital and WHSP Holdings, citing significant undervaluation and confidence in its new CEO’s growth strategy.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.